BIC GIPUZKOA, Business and Innovation Center created in 1993, acts as a key facilitator agent in the process of creating new, innovative and/or Technology based businesses, as well as an active agent in the support and promotion of entrepreneurial culture in Gipuzkoa. BIC GIPUZKOA has become an important engine in regional development, with capacity to anticipate, adapt and respond to the concrete needs of entrepreneurs and start-ups in Gipuzkoa, inspiring innovation and development of the business activity of its geographic surroundings, through an extensive collaboration with the Technology Centres,Universities, Companies, Private and Public Institutions.
BIC GIPUZKOA, has a strong experience in supporting entrepreneurs and entreprenur teams through the start-up creation process. BIC GIPUZKOA provides access to experts, funding, advanced infrastructure. Highly specialised in Technological startups, in the field os lifesciences, advanced manufacturing, new materials, ICTs.
The regional institutions are promoting and implementan a Strategy to launch and develop the Biotechnological sector in the territory .
Gipuzkoa has a particularly promising biotechnological potential: the robust institutional ecosystem of R & D, with international excellence of various groups and research centers, the existence of a consolidated health system, by the growing fabric of biotechnology companies; as well as the existence of various R & D infrastructure (Science and Technology Park, Technology Centres, Cooperative Research Centres, Institute of Biomedical research …) and powerful industry with groups who are potential users of biotechnology.
In the field of Lifesciences, BIC GIPUZKOA facilitates a specific programme for Biotech projects:
* A very professional networking with broad experience in Biotech startups, markets , regulatory, IPR, etc.
* Funding programes for different stages of BIoTech projects and companies.
* Training with highly specialised expertos.
* Well conditioned infrastructure with laboratories and specific spaces for Biotech companies .